Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling
Clinically, breast cancer is generally classified into estrogen receptor-positive (ER+) or estrogen receptor-negative (ER-) subtypes. The phytoestrogen calycosin has been shown to inhibit the proliferation of ER+ cells, which may be mediated by a feedback loop that involves miR-375, RAS dexamethason...
Saved in:
Published in | Journal of experimental & clinical cancer research Vol. 36; no. 1; p. 153 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
02.11.2017
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!